Streetbeat News

Stock Prices

BTCUSD

Bitcoin is trading higher after Donald Trump advocated for a strategic national crypto stockpile and said he would fire SEC Chair Gary Gensler.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:19 am

IOVA

Iovance Biotherapeutics shares are trading lower after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $19 to $10.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:15 am

ABIO

ANIX

The article highlights recent insider transactions for penny stocks, including ARCA biopharma, Anixa Biosciences, Lifeloc Technologies, and Cyanotech. Insider buying can indicate confidence in the company's prospects.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 11:13 am

TSLA

Tesla faced a challenging week with weaker-than-expected Q2 earnings and the lowest profit margins in five years. Despite these setbacks, Morgan Stanley analyst Adam Jonas defended Tesla's stock, emphasizing the potential of its non-automotive divisions like energy, AI, and robotics. Jonas maintained a $310 price target, highlighting the record deployment of energy storage products. Other analysts had mixed reactions, with some criticizing Tesla's strategy and margins.

Portfolio Pulse from Navdeep Yadav

July 29, 2024 | 11:13 am

ARLP

Alliance Resource Partners has updated its 2024 guidance for coal sales volumes, now expecting 33.50M-34.50M short tons, down from the prior 34.0M-35.8M short tons. The adjustment is due to declining net back pricing for high sulfur Illinois Basin coal, leading to a slowdown in production for the latter half of the year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:08 am

NOG

Northern Oil and Gas (NOG) plans to increase its Q3 dividend by 5% to $0.42 per share. The company repurchased 895,076 shares in Q2 2024 and 1,444,432 shares in H1 2024, allocating $55 million to share repurchases and $80 million to dividends year-to-date. NOG's Board approved a new $150 million stock repurchase authorization in July 2024.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:08 am

ELDN

Eledon Pharmaceuticals has enrolled the 80th participant in its Phase 2 BESTOW trial of Tegoprubart, aimed at preventing rejection in kidney transplantation. The company is on track to complete enrollment by the end of the year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:07 am

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) reported positive Phase 2 results for its Alzheimer's drug, CT1812. Participants in the study showed cognitive improvement compared to placebo across various measures. The findings were presented at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:05 am

ARLP

Alliance Resource Partners (NASDAQ: ARLP) reported Q2 2024 earnings of $0.77 per share, missing the analyst estimate of $0.95. Sales were $593.35 million, below the $632.338 million estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:04 am

MCD

McDonald's shares are trading lower following worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:02 am